Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqGS - Nasdaq Real Time Price USD

Merit Medical Systems, Inc. (MMSI)

Compare
103.94
+0.67
+(0.65%)
At close: March 28 at 4:00:01 PM EDT
103.94
0.00
(0.00%)
After hours: March 28 at 5:31:58 PM EDT
Loading Chart for MMSI
  • Previous Close 103.27
  • Open 103.81
  • Bid 103.71 x 200
  • Ask 104.12 x 300
  • Day's Range 101.92 - 104.29
  • 52 Week Range 70.70 - 111.45
  • Volume 569,855
  • Avg. Volume 597,979
  • Market Cap (intraday) 6.115B
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 51.20
  • EPS (TTM) 2.03
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 118.36

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. It also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate structures; gastroenterology products, such as covered esophageal stents, syringe and gauges, and balloon dilators; and kits and accessories for endoscopy and bronchoscopy procedures, as well as non-pharmacological treatment of gastroesophageal reflux disease. It sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

www.merit.com

7,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MMSI

View More

Performance Overview: MMSI

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MMSI
7.46%
S&P 500 (^GSPC)
5.11%

1-Year Return

MMSI
37.21%
S&P 500 (^GSPC)
6.22%

3-Year Return

MMSI
64.31%
S&P 500 (^GSPC)
21.97%

5-Year Return

MMSI
243.38%
S&P 500 (^GSPC)
119.59%

Compare To: MMSI

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MMSI

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    6.12B

  • Enterprise Value

    6.53B

  • Trailing P/E

    51.20

  • Forward P/E

    28.41

  • PEG Ratio (5yr expected)

    2.47

  • Price/Sales (ttm)

    4.55

  • Price/Book (mrq)

    4.43

  • Enterprise Value/Revenue

    4.82

  • Enterprise Value/EBITDA

    22.08

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.87%

  • Return on Assets (ttm)

    4.20%

  • Return on Equity (ttm)

    9.32%

  • Revenue (ttm)

    1.36B

  • Net Income Avi to Common (ttm)

    120.36M

  • Diluted EPS (ttm)

    2.03

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    376.72M

  • Total Debt/Equity (mrq)

    57.61%

  • Levered Free Cash Flow (ttm)

    179.41M

Research Analysis: MMSI

View More

Company Insights: MMSI

Research Reports: MMSI

View More

People Also Watch